Navigation Links
Stevens conference explores latest innovations in antimicrobial biomaterials research
Date:6/2/2011

On June 9-10, Stevens Institute of Technology will host the Stevens Conference on Bacteria-Material Interactions, an event that covers the latest multi-disciplinary research in the area of infection-resistant biomaterials. Featuring a dinner keynote from Dr. J. William Costerton, a leading developer of the biofilm paradigm, the conference will confront important issues and questions at the interfaces between biomaterials science, microbiology, cell biology, and biodetection. The event will be held in the Babbio Center on Stevens Hoboken, NJ campus just minutes from midtown Manhattan, with an evening reception at the W Hotel in Hoboken.

"Our aging population is driving the need for rapid innovation in the study of biocompatible materials that are making orthopedic implants safer and more reliable for both patients and surgeons," says Dr. Michael Bruno, Dean of the Charles V. Schaefer, Jr. School of Engineering and Science. "This conference addresses the cutting edge of research with many potential applications for science and medicine."

The Stevens Conference on Bacteria-Material Interactions complements the University's support of collaborative, on-site research into the areas of infection-resisting biomaterials. Invited speakers, rapid-fire paper presentations, a panel discussion, and multiple poster sessions will provide both broad and targeted views into research, development, and bench and clinical practice. Topics covered will include clinical needs, biofilms and antimicrobial resistance, new approaches to evaluate biomaterials efficacy, surfaces to control bacterial colonization, materials that reduce infection and promote healing, bacteria detection, and computational microbiology.

Attending the conference will be researchers from academia, government, and independent laboratories from across the United States as well as the Netherlands, Mexico, Switzerland, and Ireland. Government scientists will include employees of the FDA, NIH, and NIST. The program chair and conference contact is Dr. Matthew Libera, Professor of Chemical Engineering and Materials Science at Stevens, who is working with an interdisciplinary team of Stevens colleagues on infection-resisting biomaterials research.

Researchers at Stevens are at the forefront of technological advance in the field of biomaterials-associated infection, tissue engineering, computational biology, and next-generation antimicrobial materials and surfaces that incorporate nanotechnology and new production methods, such as inkjet-printed pharmaceuticals. These various research efforts are supported by the Coulter Foundation, the National Institute of Health, the Arbeitsgemeinschaft fr Osteosynthesefragen, and multiple National Science Foundation grants. Stevens also partners will other organizations in the State of New Jersey, such as the University of Medicine and Dentistry of New Jersey and the Public Health Research Institute.


'/>"/>

Contact: Christine del Rosario
cdelrosa@stevens.edu
201-216-5561
Stevens Institute of Technology
Source:Eurekalert

Related biology news :

1. Stevens awarded $1M for advanced biofuels research
2. Stevens strengthens Dominican Republics Early Warning System for Inundations
3. Stevens receives $25,000 grant from the Engineering Information Foundation
4. Stevens Center for Science Writings presents: Ravens at the Feast, with Bernd Heinrich, April 1
5. Stevens hosts Green Building: The Bottom Line, April 8
6. Stevens to host 2009 N.J. Inventors Hall of Fame Dinner
7. First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4
8. Stevens team wins First Place in ISPE Student Poster Competition
9. Stevens and TNO to collaborate on maritime security
10. Prof. Xiaoguang Meng receives honorary master of engineering from Stevens
11. Nanowire research at Stevens makes cover of Applied Physics Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell ... will allow them to produce up to one ... one lot within one week. These high-quality, consistent ... laboriously preparing cells and spend more time doing ... through a proprietary, high-volume manufacturing process that produces ...
Breaking Biology Technology: